Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
04/21/2005 | US20050085509 KInase inhibitors; antiarthritic agents; autoimmune diseases; sepsis; cachexia; Alzheimer's disease; antihistamines; thrombosis; glomerulonephritis; inflammatory bowel disorders; crohn's disese; multiple sclerosis; antitumor agents; skin disorders |
04/21/2005 | US20050085494 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
04/21/2005 | US20050085491 Novel crystalline forms of valacyclovir hydrochloride |
04/21/2005 | US20050085480 Water-soluble phenylpyridazine compounds and compositions containing the same |
04/21/2005 | US20050085476 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
04/21/2005 | US20050085448 Viricides against herpes virus; autoimmune disease; antitumor agents |
04/21/2005 | US20050085416 Stabilized albumin, fatty acid complex; anticancer agents; bactericides |
04/21/2005 | US20050085413 Dimeric pharmaceutical compounds and their use |
04/21/2005 | US20050084947 Recombinant RSV virus expression systems and vaccines |
04/21/2005 | US20050084897 DNA encoding human vanilloid receptor VR3 |
04/21/2005 | US20050084861 Methods of detecting modification of genetic material and monitoring processes thereof |
04/21/2005 | US20050084845 Immunoglobulin specific to hepatitis c viral envelope protein for use as tool prevention and treatment of viral diseases |
04/21/2005 | US20050084553 Composition containing moutan root bark extract as active ingredient |
04/21/2005 | US20050084552 Pharmaceutical composition of chinese herbs for treating snuffle, headache and the use thereof |
04/21/2005 | US20050084521 A non-aqueous adhesive layer on a side of the support and comprising an adhesive and a vaporizable antimicrobial agent; antimicrobial adhesive sheet has a moisture permeability of at least 1,000 g/m2*24 hrs; exerts the antimicrobial activity not only on an attached site but also in the space by the site |
04/21/2005 | US20050084503 Continuous cell line for the production of vaccines |
04/21/2005 | US20050084502 Equine herpesvirus vaccine |
04/21/2005 | US20050084486 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
04/21/2005 | US20050084482 As an antiinflammatory agent for gastrointestinal inflammation involved with inflammatory bowel disease or irritable bowel syndrome |
04/21/2005 | US20050084463 Antiinflammatory, antiarthritic agents, analgesics for pain caused by diabetic assoicated conditions, pneumoconiosis, angina, menstruation or cancer |
04/21/2005 | CA2578473A1 Peptide nucleic acid conjugates and uses thereof |
04/21/2005 | CA2541582A1 Indoles and azaindoles as antiviral agents |
04/21/2005 | CA2539449A1 Pharmaceutical formulations of xanthogenates and inhibitors of viral nucleic acid replication (e.g. aciclovir) |
04/21/2005 | CA2538106A1 Antimicrobial compositions comprising modified catechins and methods of use therein |
04/21/2005 | CA2535982A1 Uses of interferons with altered spatial structure |
04/20/2005 | EP1524263A1 prodrugs containing cycloalkene derivatives |
04/20/2005 | EP1523998A2 Antimicrobial adhesive sheet and antimicrobial method using the same |
04/20/2005 | EP1523997A1 A medical dressing comprising an antimicrobial silver compound |
04/20/2005 | EP1523992A1 Vaccine formulation against Gumboro disease |
04/20/2005 | EP1523990A1 Cellular vesicles denoted as 'exosomes', their preparation and use in the stimulation of an immune response |
04/20/2005 | EP1523982A2 Plenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
04/20/2005 | EP1523887A2 Synergistic microbicidal combinations |
04/20/2005 | EP1523582A2 Rapid, efiicient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
04/20/2005 | EP1523556A1 Methods of treating conditions associated with an edg-1 receptor |
04/20/2005 | EP1523489A2 Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
04/20/2005 | EP1523488A1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
04/20/2005 | EP1523471A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
04/20/2005 | EP1523470A1 Novel compounds as histone deacetylase inhibitors |
04/20/2005 | EP1523332A1 Medicament for the treatment of diseases due to infection by neisseria meningitidis |
04/20/2005 | EP1523331A2 Therapeutic tb vaccine |
04/20/2005 | EP1523330A2 Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells |
04/20/2005 | EP1523328A2 Methods and compositions for inhibiting hiv replication |
04/20/2005 | EP1523324A1 Treatment of serious infections and septic shock |
04/20/2005 | EP1523320A1 Megasphaera elsdenii strain and its uses |
04/20/2005 | EP1523310A2 Method to inhibit ischemia and reperfusion injury |
04/20/2005 | EP1523239A1 Use of a composition and a cleaning tablet containing said composition for disinfecting purposes |
04/20/2005 | EP1443921B1 Production of pure stereoisomers of tricyclo-[5.2.1.0(2.6)]-dec-9-yl-xanthate esters and their use as medicaments |
04/20/2005 | EP1363626A4 Antifungal remedy formulation for external application |
04/20/2005 | EP1357951B1 A medical dressing comprising an antimicrobial silver compound |
04/20/2005 | EP1315807B1 Chimeric antisense oligonucleotides of arabinofuranose analogues and deoxyribose nucleotides |
04/20/2005 | EP1292712A4 Means and methods for monitoring antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
04/20/2005 | EP1254161B1 Aerothricin analogs, their preparation and use |
04/20/2005 | EP1254133B1 Indol-3-yl derivatives and their use as integrin inhibitors |
04/20/2005 | EP1252158B1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
04/20/2005 | EP1210330B1 Antibacterial agents |
04/20/2005 | EP1185649B1 The myostatin gene promoter and inhibition of activation thereof |
04/20/2005 | EP1175435B1 Cephaibols, novel antiparasitics from acremonium tubakii, method for the production and the utilization thereof |
04/20/2005 | EP1113817B1 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies |
04/20/2005 | EP1082093B8 Anti-germ attachment - composition |
04/20/2005 | EP1059911B1 Formulations with an anti-viral effect |
04/20/2005 | EP1049481B1 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same |
04/20/2005 | EP0989994B1 Streptogramines, their preparation and compositions containing them |
04/20/2005 | EP0984947B1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
04/20/2005 | EP0954278B1 Pharmaceutical compositions containing kukui nut oil |
04/20/2005 | EP0917471B1 Treatment and diagnosis of infections of gram positive cocci |
04/20/2005 | EP0805859B1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses |
04/20/2005 | EP0759995B1 Fusion glycoprotein from hcmv and hsv |
04/20/2005 | EP0700430B1 Methods for selectively stimulating proliferation of t cells |
04/20/2005 | CN1608133A Use of a double-stranded ribonucleic acid for treating an infection with a positivestrand rna-virus |
04/20/2005 | CN1608067A Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
04/20/2005 | CN1608064A Novel compounds |
04/20/2005 | CN1607960A Glycoprotein compositions |
04/20/2005 | CN1607955A Methods and compositions for control of coccidiosis |
04/20/2005 | CN1607949A Peptide arginals and methods for treating disseminated intravascular coagulation |
04/20/2005 | CN1607948A Composition comprising paracetamol and a bitterness masking component |
04/20/2005 | CN1607942A Pharmaceutical compositions in particulate form |
04/20/2005 | CN1607941A Pharmaceutical compositions in particulate form |
04/20/2005 | CN1607937A Injectable compositions for the controlled delivery of pharmacologically active compound |
04/20/2005 | CN1607209A Poly thymosin-alpha 1, its composition, its preparation method and application |
04/20/2005 | CN1607207A S protein of SARS virus, its vaccine and method for screening medicament using it |
04/20/2005 | CN1607202A Antibiotic compound, pharmaceutical composition comprising the same and application thereof |
04/20/2005 | CN1607010A Antimicrobial adhesive sheet and antimicrobial method using the same |
04/20/2005 | CN1607004A Recombinant foot-and-mouth disease virus VP1 confluent protein vaccine |
04/20/2005 | CN1607003A Auxiliary therapeutic agent for C type hepatitis |
04/20/2005 | CN1607000A Chinese patent medicinal pill for curing syphilis and its preparation method |
04/20/2005 | CN1606991A Externally applied medicine for treating beriberi and sweaty feet |
04/20/2005 | CN1606983A Beta-L-2'deoxy-nucleosides for the treatment of hepatitis B |
04/20/2005 | CN1606982A Fluconazole formulation |
04/20/2005 | CN1606979A Effect of scutellarein as antifebrile, analgesic, antiphlogistic, antibiotic and antiviral agent |
04/20/2005 | CN1197961C BHV-1 gene-deleted virus vaccine |
04/20/2005 | CN1197877C AsLc-IFN fusion protein and its preparation |
04/20/2005 | CN1197869C Aminoglycoside compound having antiviral activity and method for preparing same |
04/20/2005 | CN1197867C Application of cinidium general coumarin as psoriasis treating medicine |
04/20/2005 | CN1197860C FAB I inhibitors |
04/20/2005 | CN1197849C 2, 3, 4, 5-tetrahydro-1H-[1, 4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
04/20/2005 | CN1197622C Emulsion-type lubricant for medical appliance and its application in medical rubber product |
04/20/2005 | CN1197620C Use of immidazoquinolinamines as adjuvants in DNA vaccination |
04/20/2005 | CN1197619C Biological therapy adjuvant originated from animal Chinese medicine |
04/20/2005 | CN1197617C Fish serine proteinases and their pharmaceutical and cosmetic use |
04/20/2005 | CN1197610C Chinese medicine preparation against cold |